Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Ghko B 2026 Mar 01, 16:01

Vanguard S&P 500 ETF forecast 2026: Will VOO stock continue to go up?

Ghko B 2026 Mar 01, 16:00

Oil price forecast 2026: Oil prices surge, will the Iran conflict drive oil prices higher?

Ghko B 2026 Feb 27, 16:00

Crypto market outlook 2026: How the Middle East is Shaping Bitcoin's Future?

Frances Wang 2026 Feb 27, 16:00

European stocks analysis: What's going on in Europe stock market?

Ghko B 2026 Feb 27, 16:00

Market Sentiment Analysis: The Impact of S&P 500 on UAE Investor Confidence

Ghko B 2026 Feb 27, 16:00

Gold (XAUUSD) price forecast: Will XAU/USD reach $6,000 per ounce?

Ghko B 2026 Feb 27, 16:00

DAX Index development analysis: Why German stocks are holding steady?

Ghko B 2026 Feb 26, 16:00

Best dividend stocks to watch: Medtronic MDT, Blackstone BX, Duke Energy DUK

Ghko B 2026 Feb 26, 16:00

Trending stocks in UAE stock market: Talabat Holding, ADNOC, Dana Gas

Ghko B 2026 Feb 25, 16:00

United Arab Emirates stock market analysis: What are the key market drivers?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.40

Spread (%)

0.6446 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

127014862848

Shares Outstanding

2036473705

Earnings Date (Next)

2001-08-07

Div Yield

2026-02-02

Ex-Dividend Date

2026-01-02

Forward annual dividend rate

2.52

Forward annual dividend yield

0.0404

EPS

3.46

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Mar 01, 16:00

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B 2026 Feb 26, 16:00

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Ghko B 2026 Feb 24, 16:00

Forex trading and currency market: how to learn to trade forex?

Trustpilot